The Valley Desk

ArticleJournal of thrombosis and haemostasis : JTHPublished

Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Journal of thrombosis and haemostasis : JTH
Published
Subject terms
Humans; Hemophilia B; Factor IX; Recombinant Fusion Proteins; Mutation; Half-Life; Adolescent; Adult; Middle Aged; Child; Child, Preschool; Female
PubMed ID
42617875
Added to directory
Source checked

Report a correction or request removal